Smoking cessation: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(New page: ==Medications== ===Rimonabant=== Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation ...)
 
imported>Robert Badgett
Line 1: Line 1:
==Medications==
==Medications==
===Rimonabant===
===Rimonabant===
Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a [[meta-analysis]] of [[randomized controlled trials]] by the [[Cochrane Collaboration]].<ref name="pmid17943852">{{cite journal |author=Cahill K, Ussher M |title=Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD005353 |year=2007 |pmid=17943852 |doi=10.1002/14651858.CD005353.pub3}}</ref> However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."<ref name="pmid17943852"/>
Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a [[meta-analysis]] of [[randomized controlled trial]]s by the [[Cochrane Collaboration]].<ref name="pmid17943852">{{cite journal |author=Cahill K, Ussher M |title=Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD005353 |year=2007 |pmid=17943852 |doi=10.1002/14651858.CD005353.pub3}}</ref> However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."<ref name="pmid17943852"/>


==References==
==References==

Revision as of 06:55, 11 December 2007

Medications

Rimonabant

Rimonabant, a selective type 1 cannabinoid (CB1) receptor antagonist, improve smoking cessation and moderate weight gain associated with smoking cessation according to a meta-analysis of randomized controlled trials by the Cochrane Collaboration.[1] However, "there is current concern (August 2007) over rates of depression and suicidal thoughts in people taking rimonabant for weight control."[1]

References

  1. 1.0 1.1 Cahill K, Ussher M (2007). "Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation". Cochrane Database Syst Rev (4): CD005353. DOI:10.1002/14651858.CD005353.pub3. PMID 17943852. Research Blogging.